Why is Indrayani Biotec falling/rising?

As of 28-Aug, Indrayani Biotech Ltd's stock price is currently at Rs. 11.55, reflecting a decrease of -0.41 (-3.43%). The stock has been on a downward trend, having lost -9.77% over the last three days and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, the stock has reached a new 52-week low of Rs. 11.2 today. The company has reported negative results for the last five consecutive quarters, with significant declines in both profit before tax and profit after tax. The weak long-term fundamentals, characterized by a -253.18% CAGR growth in operating profits over the last five years and a high debt-to-EBITDA ratio of 7.34 times, further contribute to the stock's poor performance. Furthermore, institutional investors have reduced their stakes, indicating a lack of confidence in the company's prospects.
In the broader market context, the stock's performance has been notably worse than the benchmark, with a -21.96% return over the past month compared to a -1.00% decline in the Sensex. Over the past year, Indrayani Biotech has generated a return of -75.43%, while the Sensex has only declined by -2.08%. This consistent underperformance against the benchmark, coupled with falling participation from institutional investors, highlights the stock's ongoing struggles in a challenging market environment. The floriculture sector, in which the company operates, has also seen a decline of -3.49%, further exacerbating the negative sentiment surrounding Indrayani Biotech Ltd.